CURE.DE vs. VVMX.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and VVMX.DE (VanEck Rare Earth and Strategic Metals UCITS ETF A) are both exchange-traded funds - CURE.DE is a Health & Biotech Equities fund tracking the MVIS Global Future Healthcare ESG, while VVMX.DE is a Commodity Producers Equities fund tracking the MVIS Global Rare Earth/Strategic Metals. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 3.35%/yr for VVMX.DE. At a 0.34 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.59%/yr for VVMX.DE.
Performance
CURE.DE vs. VVMX.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than VVMX.DE's 30.24% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
VVMX.DE
- 1D
- -1.82%
- 1M
- -10.31%
- YTD
- 30.24%
- 6M
- 34.99%
- 1Y
- 147.14%
- 3Y*
- 3.35%
- 5Y*
- —
- 10Y*
- —
CURE.DE vs. VVMX.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -4.35% |
VVMX.DE VanEck Rare Earth and Strategic Metals UCITS ETF A | 30.24% | 68.45% | -30.81% | -21.17% | -25.29% |
Correlation
The correlation between CURE.DE and VVMX.DE is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | 0.34 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. VVMX.DE — Risk / Return Rank
CURE.DE
VVMX.DE
CURE.DE vs. VVMX.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and VanEck Rare Earth and Strategic Metals UCITS ETF A (VVMX.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | VVMX.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.07 | ||
| Sortino ratioReturn per unit of downside risk | -3.05 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.44 | -0.38 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 7.59 | -7.29 |
| Martin ratioReturn relative to average drawdown | 0.68 | 19.66 | -18.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | VVMX.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 3.36 | -3.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.02 | -0.16 |
Drawdowns
CURE.DE vs. VVMX.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, smaller than the maximum VVMX.DE drawdown of -73.26%. Use the drawdown chart below to compare losses from any high point for CURE.DE and VVMX.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | VVMX.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -73.26% | +38.46% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -20.40% | +1.33% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -61.55% | +32.23% |
Current DrawdownCurrent decline from peak | -15.66% | -25.51% | +9.85% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -41.23% | +26.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 7.89% | +0.64% |
Volatility
CURE.DE vs. VVMX.DE - Volatility Comparison
The current volatility for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) is 5.73%, while VanEck Rare Earth and Strategic Metals UCITS ETF A (VVMX.DE) has a volatility of 12.59%. This indicates that CURE.DE experiences smaller price fluctuations and is considered to be less risky than VVMX.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | VVMX.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 12.59% | -6.86% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 32.22% | -17.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 46.13% | -26.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 36.38% | -15.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 36.38% | -15.64% |
CURE.DE vs. VVMX.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is lower than VVMX.DE's 0.59% expense ratio.
Dividends
CURE.DE vs. VVMX.DE - Dividend Comparison
Neither CURE.DE nor VVMX.DE has paid dividends to shareholders.
Frequently Asked Questions
CURE.DE and VVMX.DE have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CURE.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CURE.DE is cheaper with a 0.35% expense ratio, compared with 0.59% for VVMX.DE.
CURE.DE is categorized as Health & Biotech Equities, while VVMX.DE is Commodity Producers Equities. CURE.DE tracks MVIS Global Future Healthcare ESG, while VVMX.DE tracks MVIS Global Rare Earth/Strategic Metals. Their fees differ too: 0.35% for CURE.DE and 0.59% for VVMX.DE.
Find the right allocation for CURE.DE and VVMX.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer